{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:45Z","timestamp":1707523965588},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,23]]},"DOI":"10.7759\/cureus.47545","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T03:05:10Z","timestamp":1698116710000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Hypertensive Emergency in the Setting of Primary Aldosteronism Complicated by Heart Failure With Reduced Ejection Fraction"],"prefix":"10.7759","author":[{"given":"Tauseef","family":"Sarguroh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliziya","family":"Punjwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder JW","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al.. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008, 93:3266-81. 10.1210\/jc.2008-0104","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero P","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, et al.. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004, 89:1045-50. 10.1210\/jc.2003-031337","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder JW","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, et al.. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:1889-916. 10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-021-00220-y","article-title":"Adrenal vein sampling: technique and protocol, a systematic review","volume":"4","author":"Quencer KB","year":"2021","unstructured":"Quencer KB. Adrenal vein sampling: technique and protocol, a systematic review. CVIR Endovasc. 2021, 4:38. 10.1186\/s42155-021-00220-y","journal-title":"CVIR Endovasc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young WF Jr","year":"2019","unstructured":"Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019, 285:126-48. 10.1111\/joim.12831","journal-title":"J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.08.026","article-title":"Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension","volume":"18","author":"Mahmud A","year":"2005","unstructured":"Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005, 18:50-5. 10.1016\/j.amjhyper.2004.08.026","journal-title":"Am J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-00426-y","article-title":"Left ventricular remodeling and dysfunction in primary aldosteronism","volume":"35","author":"Tsai CH","year":"2021","unstructured":"Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC, Hung CS, Lin YH. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens. 2021, 35:131-47. 10.1038\/s41371-020-00426-y","journal-title":"J Hum Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4137\/CMT.S2211","article-title":"Safety and efficacy of eplerenone in the management of essential hypertension","volume":"1","author":"McManus F","year":"2009","unstructured":"McManus F, Connell J. Safety and efficacy of eplerenone in the management of essential hypertension. Clin Med Ther. 2009, 1:1121-30. 10.4137\/CMT.S2211","journal-title":"Clin Med Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt B","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999, 341:709-17. 10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad F","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, et al.. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011, 364:11-21. 10.1056\/NEJMoa1009492","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2020.29","article-title":"Optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization","volume":"15","author":"Dixit NM","year":"2021","unstructured":"Dixit NM, Shivani S, Boback Z, et al.. Optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization. US Cardiology Review. 2021, 15:3. 10.15420\/usc.2020.29","journal-title":"US Cardiology Review"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1470320313482603","article-title":"Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure","volume":"16","author":"Rossi R","year":"2015","unstructured":"Rossi R, Crupi N, Coppi F, Monopoli D, Sgura F. Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure. J Renin Angiotensin Aldosterone Syst. 2015, 16:119-25. 10.1177\/1470320313482603","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172070","article-title":"Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter","volume":"12","author":"Kreusser MM","year":"2017","unstructured":"Kreusser MM, Lehmann LH, Haass M, Buss SJ, Katus HA, Lossnitzer D. Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter. PLoS One. 2017, 12:e0172070. 10.1371\/journal.pone.0172070","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/188941-management-of-hypertensive-emergency-in-the-setting-of-primary-aldosteronism-complicated-by-heart-failure-with-reduced-ejection-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:01Z","timestamp":1707508501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/188941-management-of-hypertensive-emergency-in-the-setting-of-primary-aldosteronism-complicated-by-heart-failure-with-reduced-ejection-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.47545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}